Clarivate (NYSE:CLVT) Updates FY 2026 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus earnings per share estimate of 0.720. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion.

Clarivate Price Performance

CLVT opened at $2.58 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. The firm has a market cap of $1.65 billion, a P/E ratio of -12.26 and a beta of 1.38. Clarivate has a fifty-two week low of $1.66 and a fifty-two week high of $4.77. The firm has a 50-day moving average of $2.41 and a 200 day moving average of $2.58.

Clarivate (NYSE:CLVT) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million during the quarter, compared to analyst estimates of $569.50 million. During the same quarter last year, the business posted $0.14 EPS. Clarivate’s quarterly revenue was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, research analysts expect that Clarivate will post 0.65 EPS for the current year.

Analysts Set New Price Targets

Several research analysts recently issued reports on CLVT shares. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Five research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $3.22.

Hedge Funds Weigh In On Clarivate

Institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its holdings in Clarivate by 96.2% in the first quarter. Royal Bank of Canada now owns 63,630 shares of the company’s stock worth $250,000 after acquiring an additional 31,197 shares in the last quarter. AQR Capital Management LLC boosted its stake in Clarivate by 37.0% in the 1st quarter. AQR Capital Management LLC now owns 451,872 shares of the company’s stock worth $1,749,000 after purchasing an additional 122,099 shares in the last quarter. Millennium Management LLC grew its position in Clarivate by 1,420.4% during the 1st quarter. Millennium Management LLC now owns 1,188,978 shares of the company’s stock valued at $4,673,000 after purchasing an additional 1,110,774 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Clarivate by 15.5% in the first quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company’s stock worth $2,422,000 after buying an additional 82,768 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Clarivate by 13.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company’s stock worth $4,888,000 after buying an additional 144,462 shares during the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.